Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

AustriaBack to Austria

Clinical trials in Mattersburg

5 clinical trials in Mattersburg, Austria. Every trial is listed in the EU Clinical Trials Register and updated daily.

Mattersburg at a glance
5
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

5 trials in Mattersburg

Open in trial search

Arteriosclerosis

Recruiting
Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.

Chronic kidney disease+1

Recruiting
Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.

Arteriosclerosis

Not yet recruiting
Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.

Arteriosclerosis

Not yet recruiting
Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.

Obesity

Not recruiting
InvestigationalNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Other cities in Austria

The busiest research cities in the country

All 47 cities in Austria

Clinical research in Mattersburg

What the registry says about research in the country

01 Mattersburg
Cardiovascular Diseases
In Mattersburg, clinical trial activity in cardiovascular diseases is focused on reducing the risk of serious heart complications and improving long-term outcomes for people with atherosclerotic cardiovascular disease. Studies in atherosclerotic cardiovascular disease and broader cardiovascular disease Research on preventing major heart events and related complications Work aimed at improving treatment effectiveness for high-risk patients These trials are helping assess whether new therapies can better protect patients from heart attacks, cardiovascular death, and other major events.
Nutritional and Metabolic Diseases
Clinical research in nutritional and metabolic diseases in this Austrian city is closely linked to obesity, overweight, and related metabolic risk factors that can affect heart and kidney health. Trials involving obesity and overweight Studies connecting weight-related conditions with cardiovascular disease Research evaluating new approaches to improve metabolic health The main goal is to understand whether emerging treatments can lower long-term disease burden and support better prevention.
Cardiovascular Risk Reduction
Several trials are examining whether investigational therapies can reduce the chance of first or repeat major cardiovascular events in participants with elevated risk factors. Atherosclerotic Cardiovascular Disease and event prevention Elevated Lp(a) as a key risk factor under study Testing new options to reduce heart-related morbidity and mortality This research focuses on whether better risk control can help prevent heart attacks, urgent procedures, and other serious outcomes.
Kidney and Cardiometabolic Health
Some studies also look beyond the heart, examining whether treatments can help preserve kidney function in people with overlapping cardiometabolic conditions. Chronic Kidney Disease in combination with heart risk People living with obesity and related complications Trials exploring whether therapy can support both heart and kidney outcomes These projects aim to find approaches that address multiple health concerns at once, which is especially important for patients with complex chronic disease.
Lipoprotein(a) Research
A notable area of investigation is Lipoprotein(a), or Lp(a), where researchers are testing whether lowering this inherited risk marker can reduce cardiovascular events. Elevated Lp(a) and first major cardiovascular events Studies focused on preventing coronary heart disease and myocardial infarction Evaluating new strategies for people at heightened genetic risk This work could improve prevention for patients whose heart risk remains high despite standard care.
Back to AustriaAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.